PAOG Schedules Acquisition Closing Dates For Tuesday and Thursday Next Week
Sandusky, OH -- July 24, 2020 --
InvestorsHub NewsWire -- PAO Group, Inc. (USOTC:
PAOG) today announced the company has scheduled to close the
acquisition of Puration, Inc.’s (USOTC:
PURA) cannabis spinoff next week, on Tuesday, July 28,
2020. PAOG has further scheduled to close the acquisition of
Kali-Extracts’s (USOTC:KALY)
NCM Biotech subsidiary next week, on Thursday, July 30,
2020.
NCM Biotech has
patented cannabis extraction operation which is focused on medical
research and the development of treatments derived from its
patented cannabis extraction process. See a recent research report
on CBD extracts derived from NCM Biotech's patented extraction
process: Journal
of Cannabis Research.
PURA’s cannabis
cultivation operation is thriving, has revenue, and has recently
purchased and relocated to a new property from its former leased
property. Texas lawmakers have recently implemented hemp
friendly farming regulations and in so doing, universities within
the State of Texas have initiated hemp farming research
programs. PURA's cannabis cultivation spinoff has initiated a
number of joint research applications
with Texas universities.
PURA had
previously spun-off its cannabis cultivation operation to Nouveau
(USOTC:
NOUV) and is now unwinding that deal to move forward with
PAOG.
Forward-Looking
Statements: Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933 and Rule 3b-6 under the Securities
Exchange Act of 1934, and are subject to the safe harbor created by
those rules. All statements, other than statements of fact,
included in this release, including, without limitation, statements
regarding potential future plans and objectives of the company are
forward-looking statements that involve risks and uncertainties.
There can be no assurance that such statements will prove to be
accurate and actual results and future events could differ
materially from those anticipated in such statements. Technical
complications, which may arise, could prevent the prompt
implementation of any strategically significant plan(s) outlined
above. The Company undertakes no duty to revise or update any
forward-looking statements to reflect events or circumstances after
the date of this release.
CONTACT
INFORMATION
Contact Us:
Jim DiPrima
888-272-6472
info@pao.group
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
過去 株価チャート
から 11 2024 まで 12 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Nouveau Life Pharmaceuticals Inc (PK) (その他OTC): 0 recent articles
その他のNouveau Life Pharmaceuticals Inc (PK)ニュース記事